Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis
Ulrike Peters ; Shuo Jiao ; Li Hsu ; Wei Zheng ; Ben Zhang ; Yi-Xin Zeng ; Brent W. Zanke ; Yongbing Xiang ; Emily White ; Cornelia M. Ulrich ; Stephen N. Thibodeau ; Darin Taverna ; Martha L. Slattery ; Xiao-Ou Shu ; Martha Shrubsole ; Daniela Seminara ; Robert E. Schoen ; Stephanie A. Rosse ; Thomas Rohan ; Conghui Qu ; Ross L. Prentice ; John D. Potter ; Polly A. Newcomb ; Keitaro Matsuo ; Karen W. Makar ; Jing Ma ; Yan Liu ; Noralane M. Lindor ; David Levine ; Mathieu Lemire ; Loic Le Marchand ; Cecelia A. Laurie ; Cathy C. Laurie ; Andrea Z. Lacroix ; Sébastien Küry ; Charles Kooperberg ; Laurence N. Kolonel ; Wei-Hua Jia ; Mark A. Jenkins ; Sun Ha Jee ; Rebecca D. Jackson ; David J. Hunter ; Thomas J. Hudson ; John L. Hopper ; Michael Hoffmeister ; Brian E. Henderson ; Richard B. Hayes ; Tabitha A. Harrison ; Robert W. Haile ; Stephen B. Gruber ; Stephanie M. Gogarten ; Edward L. Giovannucci ; Steven Gallinger ; Charles S. Fuchs ; Todd Edwards ; David Duggan ; Keith R. Curtis ; David V. Conti ; Simon G. Coetzee ; Gerhard A. Coetzee ; Lin S. Chen ; Stephen J. Chanock ; Jenny Chang-Claude ; Andrew T. Chan ; Graham Casey ; Christopher S. Carlson ; Peter T. Campbell ; Bette J. Caan ; Katja Butterbach ; Hermann Brenner ; Stéphane Bézieau ; Sonja I. Berndt ; John A. Baron ; Aaron K. Aragaki ; Carolyn M. Hutter ; Fredrick R. Schumacher
Gastroenterology , Vol.144(4) : 799~807, 2013
BACKGROUND & AIMS:
Heritable factors contribute to the development of colorectal cancer. Identifying the genetic loci associated with colorectal tumor formation could elucidate the mechanisms of pathogenesis.
We conducted a genome-wide association study that included 14 studies, 12,696 cases of colorectal tumors (11,870 cancer, 826 adenoma), and 15,113 controls of European descent. The 10 most statistically significant, previously unreported findings were followed up in 6 studies; these included 3056 colorectal tumor cases (2098 cancer, 958 adenoma) and 6658 controls of European and Asian descent.
Based on the combined analysis, we identified a locus that reached the conventional genome-wide significance level at less than 5.0 × 10(-8): an intergenic region on chromosome 2q32.3, close to nucleic acid binding protein 1 (most significant single nucleotide polymorphism: rs11903757; odds ratio [OR], 1.15 per risk allele; P = 3.7 × 10(-8)). We also found evidence for 3 additional loci with P values less than 5.0 × 10(-7): a locus within the laminin gamma 1 gene on chromosome 1q25.3 (rs10911251; OR, 1.10 per risk allele; P = 9.5 × 10(-8)), a locus within the cyclin D2 gene on chromosome 12p13.32 (rs3217810 per risk allele; OR, 0.84; P = 5.9 × 10(-8)), and a locus in the T-box 3 gene on chromosome 12q24.21 (rs59336; OR, 0.91 per risk allele; P = 3.7 × 10(-7)).
In a large genome-wide association study, we associated polymorphisms close to nucleic acid binding protein 1 (which encodes a DNA-binding protein involved in DNA repair) with colorectal tumor risk. We also provided evidence for an association between colorectal tumor risk and polymorphisms in laminin gamma 1 (this is the second gene in the laminin family to be associated with colorectal cancers), cyclin D2 (which encodes for cyclin D2), and T-box 3 (which encodes a T-box transcription factor and is a target of Wnt signaling to β-catenin). The roles of these genes and their products in cancer pathogenesis warrant further investigation.